These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma. Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660 [TBL] [Abstract][Full Text] [Related]
12. [Locally advanced and metastatic cutaneous squamous cell carcinoma treated with cemiplimab]. Vanhakendover L; Lebas E; Libon F; Wauters O; Dezfoulian B; Marchal N; Rorive A; Piret P; Quatresooz P; Jacquemin D; Nikkels AF Rev Med Liege; 2019 Jul; 74(7-8):436-440. PubMed ID: 31373461 [TBL] [Abstract][Full Text] [Related]
13. Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma. Lee A; Duggan S; Deeks ED Drugs; 2020 Jun; 80(8):813-819. PubMed ID: 32306208 [TBL] [Abstract][Full Text] [Related]
14. Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma. Ahmed SR; Petersen E; Patel R; Migden MR Expert Rev Clin Pharmacol; 2019 Oct; 12(10):947-951. PubMed ID: 31524530 [No Abstract] [Full Text] [Related]
15. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. Baggi A; Quaglino P; Rubatto M; Depenni R; Guida M; Ascierto PA; Trojaniello C; Queirolo P; Saponara M; Peris K; Spagnolo F; Bianchi L; De Galitiis F; Potenza MC; Proietti I; Marconcini R; Botticelli A; Barbieri V; Licitra L; Alfieri S; Ficorella C; Cortellini A; Fargnoli MC; Troiani T; Tondulli L; Bossi P Eur J Cancer; 2021 Nov; 157():250-258. PubMed ID: 34536948 [TBL] [Abstract][Full Text] [Related]
16. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ; Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942 [TBL] [Abstract][Full Text] [Related]
17. Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios. Akhtar K; Sravanthi MV; D'Angelo J; Sivapiragasam A J Investig Med High Impact Case Rep; 2022; 10():23247096221121408. PubMed ID: 36017984 [TBL] [Abstract][Full Text] [Related]
18. Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma. Lai FY; Clarke R; Cooper P; Stokes J; Calvert P Case Rep Oncol; 2023; 16(1):1156-1165. PubMed ID: 37900839 [TBL] [Abstract][Full Text] [Related]
19. Libtayo Gupta AK; Mann A; Vincent K; Abramovits W Skinmed; 2024; 22(2):138-143. PubMed ID: 39090000 [TBL] [Abstract][Full Text] [Related]
20. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report. Ashraf S; Alsharedi M Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]